ArticleActa obstetricia et gynecologica Scandinavica2026
Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population-based birth cohort study.
Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Delayed menopausal transition in polycystic ovary syndrome: A call for research on age-dependent phenotypes and different ethnic populations.Acta obstetricia et gynecologica Scandinavica · 2026Article
- Polycystic ovary syndrome and menopausal transition: Hormonal dynamics, phenotypic evolution, and ethnic considerations.Acta obstetricia et gynecologica Scandinavica · 2026Article
- Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population-based birth cohort study.Acta obstetricia et gynecologica Scandinavica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionWomen with polycystic ovary syndrome (PCOS) have been suggested to experience later menopause, yet population-based studies are lacking. The present study aimed to assess, in a population-based birth cohort, whether women with PCOS are more likely to experience late peri-/postmenopause or to have menopausal symptoms in their mid-40s than women without the syndrome. MATERIAL AND
methodsThe present study is a long-term, population-based prospective cohort study from the Northern Finland Birth Cohort 1966 (NFBC1966). The PCOS group (n = 380) was identified based on the Rotterdam criteria (oligomenorrhea, hyperandrogenism, or polycystic ovarian morphology according to anti-Müllerian hormone levels). Women who did not meet the Rotterdam criteria for PCOS were considered as controls (n = 1469). Late peri-/postmenopause was defined as at least 60 days of amenorrhea accompanied by elevated follicle-stimulating hormone levels (>25 IU/L) or the use of menopausal hormone therapy. In women who had undergone hysterectomy or were using progestins, menopausal status was defined as elevated follicle-stimulating hormone levels (>25 IU/L). Menopausal symptoms were self-reported via questionnaire during a follow-up visit at age 46.
resultsWomen with PCOS had a significantly lower likelihood of being late peri-/postmenopausal in their mid-40s compared with controls (PCOS: 3.1% vs. Controls: 18.4%; adjusted odds ratio 0.15, 95% confidence interval 0.07-0.32). To support this result, women with PCOS more often reported having regular menstrual cycles and had a lower risk of menopausal symptoms at age 46, even after adjusting for body mass index, education, and smoking status (adjusted odds ratio 0.68, 95% confidence interval 0.51-0.92). Hot flashes and sleep disturbances were less frequent among women with PCOS, but there were no differences in other menopause-related symptoms, such as vaginal dryness, affective symptoms, memory disturbances, or sexual dysfunction between the study groups.
conclusionsFrom the nonselective population data, it was shown that late peri-/postmenopausal status and symptoms were less frequent in women with PCOS at age 46, supporting the idea of prolonged ovarian function in affected women. This should be considered in patient counseling and future studies of fertility, contraception, and menopausal hormone therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.